Abstract
From the updates published in this volume, is it possible to answer the following question: Does presurgical chemotherapy followed by adjuvant chemotherapy after definitive surgery produce a higher disease-free survival than the traditional approach of definitive surgery followed by adjuvant chemotherapy? We feel that the answer is probably not. Can some insight be gained from what is included in this volume? Possibly.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Rosen G. An Opinion supporting the role of high dose methotrexate in the treatment of osteosarcoma. This volume, ch 9.
Jaffe N. Pediatric osteosarcoma: Treatment of the primary tumor with intraarterial cis-diamminedichloroplatinum-II (CDP). Advantages, disadvantages and controversial issues. This volume, ch 11.
Link M. The Multi-Institutional Osteosarcoma Study: An update. This volume, ch 30.
Winkler K. Treatment of osteosarcoma: Experience of the Cooperative Study Group. This volume, ch 31.
Bacci G, Picci P, Ferrari S, et al. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute. This volume, ch 35.
Meyers PA, Heller G, Vlamis V. Osteosarcoma of the extremities: chemotherapy experience at Memorial Sloan-Kettering. This volume, ch 36.
Pratt CB, Meyer WH, Roa BN, Parham DM, Fleming ID. Osteosarcoma studies at St. Jude Children’s Research Hospital from 1968 through 1990. This volume, ch 37.
Graham-Pole J, Ayass M, Cassano W, et al. Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida. This volume, ch 40.
Elomaa I: An update of Scandinavian studies of osteosarcoma. This volume, ch 34.
Miser JS, Pritchard DJ, Rock MG, et al. The Mayo Clinic studies. This volume, ch 39.
Kalifa C, Razafindrakoto H, Vassal G, et al. Chemotherapy in osteosarcoma: the experience of the pediatric department of the Gustave Roussy Institute. This volume, ch 41.
Delepine N, Delepine G, Desbois JC. A monocentric therapy study. An approach to optimize the results of the treatment of osteosarcoma by protocols based upon HD MTX, associated with systematic conservative surgery. This volume, ch 38.
Postma A, Kamps WA, Schraffordt Koops H, et al. An institutional report of ten years experience with neoadjuvant chemotherapy and delayed surgery. This volume, ch 44.
Humphrey GB, et al. Osteosarcoma at the end of the Twentieth Century/Tumor Biology. This volume, ch 1.
Link MP. Commentary on the use of presurgical chemotherapy. This volume, ch 50.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Humphrey, G.B. (1993). Critique on the use of presurgical chemotherapy: Recent trials as updated in this volume. In: Humphrey, G.B., Koops, H.S., Molenaar, W.M., Postma, A. (eds) Osteosarcoma in Adolescents and Young Adults: New Developments and Controversies. Cancer Treatment and Research, vol 62. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3518-8_51
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3518-8_51
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6561-7
Online ISBN: 978-1-4615-3518-8
eBook Packages: Springer Book Archive